KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $9.9 million.

  • Encompass Health's Gains from Investment Securities rose 131428.57% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 584.42%. This contributed to the annual value of $21.8 million for FY2024, which is 4695.86% down from last year.
  • Per Encompass Health's latest filing, its Gains from Investment Securities stood at $9.9 million for Q3 2025, which was up 131428.57% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Gains from Investment Securities ranged from a high of $45.6 million in Q3 2022 and a low of -$43.4 million during Q4 2022
  • Its 5-year average for Gains from Investment Securities is $6.5 million, with a median of $5.2 million in 2023.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 2680000.0% in 2021, then crashed by 190833.33% in 2022.
  • Quarter analysis of 5 years shows Encompass Health's Gains from Investment Securities stood at $2.4 million in 2021, then crashed by 1908.33% to -$43.4 million in 2022, then soared by 111.98% to $5.2 million in 2023, then tumbled by 173.08% to -$3.8 million in 2024, then soared by 360.53% to $9.9 million in 2025.
  • Its Gains from Investment Securities was $9.9 million in Q3 2025, compared to $4.2 million in Q2 2025 and $22.3 million in Q1 2025.